These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23593614)

  • 1. Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B.
    Kim EH; Park H; Lee KH; Ahn SH; Kim SM; Han KH
    Clin Mol Hepatol; 2013 Mar; 19(1):82-6. PubMed ID: 23593614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection.
    Wang L; Chen H; Fan C; Gong Z
    J Med Virol; 2013 Nov; 85(11):1907-12. PubMed ID: 23852947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telbivudine myopathy in a patient with chronic hepatitis B.
    Wang M; Da Y; Cai H; Lu Y; Wu L; Jia J
    Int J Clin Pharm; 2012 Jun; 34(3):422-5. PubMed ID: 22527478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B.
    Ying Y; Hu YK; Jin JL; Zhang JM; Zhang WH; Huang YX
    BMC Gastroenterol; 2018 Apr; 18(1):45. PubMed ID: 29625557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactic acidosis during telbivudine treatment for HBV: a case report and literature review.
    Jin JL; Hu P; Lu JH; Luo SS; Huang XY; Weng XH; Zhang JM
    World J Gastroenterol; 2013 Sep; 19(33):5575-80. PubMed ID: 24023503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy and safety of telbivudine in korean patients with chronic hepatitis B].
    Moon YM; Hwang SG; Kim BS; Rim KS; Cho M; Kim DJ; Han JY; Kim YS; Choi HS; Ahn SH
    Korean J Hepatol; 2007 Dec; 13(4):503-12. PubMed ID: 18159148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.
    He T; Bai Y; Cai H; Ou X; Liu M; Yi W; Jia J
    Hepatol Int; 2018 Mar; 12(2):118-125. PubMed ID: 29344772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of telbivudine for the management of chronic hepatitis B virus infection.
    Lui YY; Chan HL
    Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1351-61. PubMed ID: 18798704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telbivudine: a review of its use in compensated chronic hepatitis B.
    McKeage K; Keam SJ
    Drugs; 2010 Oct; 70(14):1857-83. PubMed ID: 20836578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
    Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF
    J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous venovenous hemodiafiltration for hyperlactatemia caused by telbivudine in a patient with chronic hepatitis B: a case report and update review.
    Wang YH; Wu BQ; Liu H
    J Dig Dis; 2015 Mar; 16(3):164-7. PubMed ID: 25043654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety evaluation of telbivudine.
    But DY; Yuen MF; Fung J; Lai CL
    Expert Opin Drug Saf; 2010 Sep; 9(5):821-9. PubMed ID: 20662545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telbivudine in the treatment of chronic hepatitis B.
    Nash K
    Adv Ther; 2009 Feb; 26(2):155-69. PubMed ID: 19225726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clevudine myopathy in patients with chronic hepatitis B.
    Kim BK; Oh J; Kwon SY; Choe WH; Ko SY; Rhee KH; Seo TH; Lim SD; Lee CH
    J Hepatol; 2009 Oct; 51(4):829-34. PubMed ID: 19615776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment.
    Fung J; Seto WK; Lai CL; Yuen MF
    J Gastroenterol Hepatol; 2014 Mar; 29(3):428-34. PubMed ID: 24372662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy.
    Marcellin P; Wursthorn K; Wedemeyer H; Chuang WL; Lau G; Avila C; Peng CY; Gane E; Lim SG; Fainboim H; Foster GR; Safadi R; Rizzetto M; Manns M; Bao W; Trylesinski A; Naoumov N
    J Hepatol; 2015 Jan; 62(1):41-7. PubMed ID: 25152207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telbivudine.
    Keam SJ
    Drugs; 2007; 67(13):1917-29. PubMed ID: 17722961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute liver failure resulting from discontinuation of nucleoside analogues in chronic hepatitis B patients: a report of two cases.
    Wang J; Wang M; Huang Y
    Scand J Infect Dis; 2013 Feb; 45(2):158-60. PubMed ID: 22830672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study.
    Sun J; Xie Q; Tan D; Ning Q; Niu J; Bai X; Fan R; Chen S; Cheng J; Yu Y; Wang H; Xu M; Shi G; Wan M; Chen X; Tang H; Sheng J; Dou X; Shi J; Ren H; Wang M; Zhang H; Gao Z; Chen C; Ma H; Jia J; Hou J
    Hepatology; 2014 Apr; 59(4):1283-92. PubMed ID: 24382690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis.
    Han Z; Shi Y; Zhu J; Chen Y; Yin F; Xia L; Luo G; Gao Z; Liu J; Jia G; Li C; Zhou X; Han Y
    J Viral Hepat; 2013 Apr; 20 Suppl 1():58-64. PubMed ID: 23458526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.